Asia Emerging as Hotbed for Single Use Bioprocessing Adoption

The global single-use bioprocessing market is experiencing explosive growth, projected to skyrocket from $8.2 billion in 2021 to $20.8 billion by 2026 at an impressive 20.5% compound annual growth rate (CAGR). This surge is fueled by the increasing demand for biopharmaceuticals, driven by an aging global population more susceptible to chronic conditions.


Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231651297

Single-use bioprocessing systems offer numerous advantages over traditional stainless-steel equipment, including greater energy efficiency, reduced water usage, smaller footprints, lower costs, quicker implementation, and diminished risk of cross-contamination. While concerns exist around extractables, leachables, and waste disposal, emerging markets in Asia like China and India present lucrative opportunities for this technology.

Major players like Sartorius, Danaher's Cytiva, Thermo Fisher, and Merck are making massive investments to expand single-use bioprocessing capabilities and meet soaring demand for biologics and vaccines. Thermo Fisher alone invested over $475 million in 2020 to bolster its St. Louis facilities.

The single-use media bags and containers segment currently dominates the market, driven by their widespread use across biomanufacturing processes. However, demand is strong across all application areas including filtration, storage, cell culture, mixing, and purification.

As biopharmaceutical production continues ramping up globally, the future looks extremely bright for flexible, cost-effective single-use bioprocessing solutions to unlock new manufacturing efficiencies and accelerate delivery of life-saving treatments.

Comments

Post a Comment

Popular posts from this blog

From Pain Management to Drug Delivery: The Rising Trajectory of Transdermal Patches

Image
The global transdermal patches market is poised for significant expansion in the coming years, projected to grow from $6.2 billion in 2023 to $8.0 billion by 2029 at a compound annual growth rate (CAGR) of 4.5%. This burgeoning market is driven by several key factors, including the rising prevalence of chronic diseases, the increasing adoption of analgesic patches, technological advancements in transdermal patch development, and a shift away from traditional injections toward more convenient and patient-friendly transdermal delivery systems. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=190809043 One of the primary driving forces behind this growth is the growing popularity of analgesic patches for pain management. These patches offer a localized and controlled release of painkillers through the skin, reducing the risk of systemic adverse effects associated with oral medications. Patients with chronic pain disorders are increasingly turning to anal...
Read more

Introducing the Future of Beauty: Cutting-Edge Medical Aesthetics Treatments

Image
Introduction to Medical Aesthetics: Medical aesthetics is a field of medicine that focuses on improving the appearance of the body through various treatments, such as laser treatments, chemical peels, injectables, and fillers. It is a combination of medical and cosmetic treatments, which are designed to enhance a patient’s natural beauty, while also addressing any health concerns a patient may have. Medical aesthetics has become increasingly popular in recent years, as more people seek to improve their appearance and overall health. The benefits of medical aesthetics treatments are numerous. Patients can achieve a more youthful and vibrant look, improve skin tone and texture, reduce wrinkles and fine lines, correct discoloration and sun damage, and even out skin tone. Additionally, medical aesthetic treatments can help with body contouring and scarring, as well as providing a boost to self-confidence. The results of medical aesthetic treatments can last for many months or even yea...
Read more

Scaffold Products Lead Tissue Engineering Market Growth, Driven by Orthopedic Applications

The global tissue engineering market is projected to expand from $4.4 billion in 2023 to $8.9 billion by 2028, representing a strong CAGR of 15.3%. Key growth drivers include the rising need for advanced regenerative medicines to treat chronic and degenerative diseases, as well as increasing incidence of traumatic injuries from accidents. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34135173 While high treatment costs currently restrain market growth, exciting technological advancements like 3D bioprinting, organ-on-chip technology, and Quantum Magnetic Resonance Therapy (QMRT) present attractive future growth opportunities. Traditional organ transplants remain a more cost-effective alternative currently and are a challenge the industry must overcome. The tissue engineering ecosystem involves hospitals, clinics, technology providers, regulatory bodies, and collaborative networks all working together to advance tissue engineering solutions. Sca...
Read more